ARRY-403

• Description:

  ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  454.52

• Molecular Formula:

  C20H18N6O3S2

• Notes:

  Research use only, not for human use.

• Receptor:

  Glucokinase

• CAS Number:

  1138669-65-4